Persperity Health

Cover Block

Attribute	Value
Name	Persperity Health
Tagline	Non-invasive, sweat-based hormone monitoring wearables for women's health, focusing on fertility and menopause.
Headquarters	Los Angeles, United States
Founded	2024
Stage	Pre-Seed
Business Model	Hardware + Software
Industry	Healthtech
Technology	Biotech / Life Sciences
Geography	North America
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding Label	Pre-seed
Total Disclosed	$1,000,000

Links

• Website: https://persperityhealth.com/
• LinkedIn: https://www.linkedin.com/company/persperity-health/

Summary and Signal

Persperity Health is a Caltech spinout building a non-invasive, sweat-based wearable for continuous hormone monitoring [PR Newswire, October 2024]. Founded in 2024, the company commercializes an aptamer-based biosensor platform licensed exclusively from the university [Finsmes, 2024]. The core product is a patch designed to track hormones like estradiol in real time, positioning it as a potential alternative to intermittent blood draws for managing fertility treatments and menopause [Perplexity Sonar Pro Brief].

The founding team combines technical and clinical expertise, with Dr. Wei Gao providing the sensor IP, Shiv Shukla serving as CEO, and Dr. Heather Lukas and Michelle Wong rounding out the founding group [Finsmes, 2024]. A $1 million pre-seed round led by Freeflow Ventures will fund the acceleration of platform development [PR Newswire, October 2024]. Over the next 12 to 18 months, critical milestones include the completion of clinical validation studies, the announcement of initial pilot partnerships with fertility clinics, and the transition from prototype to a manufacturable device.

Data Accuracy: GREEN -- Core facts confirmed by multiple independent sources (PR Newswire, Finsmes, Crunchbase).

Company Overview

Persperity Health was founded in 2024 as a Caltech spinout to commercialize a novel sweat-sensing biosensor platform developed in the lab of Dr. Wei Gao [Finsmes, 2024]. The company is headquartered in Los Angeles and operates as a resident startup within the LA BioSpace incubator [PR Newswire, October 2024]. Its founding narrative centers on translating academic research into a non-invasive tool for women's health, with an exclusive license to the underlying Caltech technology serving as the core intellectual property asset [Perplexity Sonar Pro Brief].

The company announced a $1 million pre-seed financing round in October 2024, led by Freeflow Ventures with participation from Caltech, Wilson Hill Ventures, Heritage Group, and ATMA Capital [PR Newswire, October 2024]. Funds are allocated to accelerating development of its wearable prototype and platform [Finsmes, 2024].

Data Accuracy: YELLOW -- Core founding and funding facts are confirmed by multiple press releases; operational details are sourced from company materials.

The Product and the Stack

Persperity Health's product is a wearable biosensor platform designed to continuously monitor key female hormones, such as estradiol, through sweat. The company's core technical claim is that its device offers "clinical-grade accuracy" with subpicomolar precision [Persperity Health]. The technology, exclusively licensed from Caltech, is based on aptamer-based sensors developed in the lab of co-founder Dr. Wei Gao [Finsmes, 2024].

The intended user experience involves a patch-like wearable that streams data to a companion mobile application [Persperity Health]. The primary use cases highlighted are managing fertility, optimizing IVF medication protocols, and tracking hormonal changes during menopause [Finsmes, 2024]. The $1 million pre-seed round closed in October 2024 is earmarked for accelerating the development of this platform [PR Newswire, October 2024].

Data Accuracy: YELLOW -- Core technology claims are sourced from the company website and press releases; the Caltech license and founding team involvement are corroborated by secondary press.

The Market They Are Entering

The market for continuous, non-invasive hormone monitoring is emerging from a convergence of unmet clinical needs in women's health and advances in biosensing technology. The global fertility services market was valued at approximately $44 billion in 2023 and is projected to grow at a compound annual rate of 9% [Grand View Research, 2024]. The global hormone replacement therapy market exceeds $21 billion [Global Market Insights, 2024].

Metric	Value
Fertility Services Market (2023)	$44B
HRT Market (2023)	$21B

Data Accuracy: YELLOW -- Market sizing figures are from third-party reports but represent adjacent, not direct, markets.

The Competitive Field

Persperity Health enters a crowded field of women’s health diagnostics, but its proposed method of continuous, sweat-based hormone monitoring carves out a distinct position. The competitive landscape includes incumbent clinical blood draw labs (e.g., Quest Diagnostics, Labcorp), digital health challengers (e.g., Modern Fertility, Mira), and adjacent technology substitutes (e.g., Eccrine Systems, Profusa).

Persperity’s defensible edge rests on its exclusive Caltech license for aptamer-based sweat-sensing technology and its early focus on estradiol [Finsmes, 2024]. The company is exposed to competition from well-capitalized digital health companies that could integrate similar capabilities into existing wearable form factors.

Data Accuracy: YELLOW -- Competitive mapping is inferred from product claims and general market knowledge.

Opportunity

If Persperity Health can successfully commercialize its sweat-sensing platform, the prize is a fundamental shift in the standard of care for female hormone monitoring. The company's core technology addresses a clear gap in current clinical practice, where the existing standard relies on sporadic, inconvenient blood tests [Persperity Health]. Dr. Pauline Maki, a clinical collaborator, leads NIH-funded research on menopause and cognition, lending scientific credibility to the targeted use cases [Finsmes, 2024].

Scenario	What happens	Catalyst
Fertility Clinic Standard	Device becomes the preferred tool for optimizing IVF protocols.	Pivotal partnership with a major national fertility clinic chain.
DTC Menopause Platform	Branded DTC subscription service for perimenopause and menopause.	Successful FDA clearance for over-the-counter use.

Data Accuracy: YELLOW -- The opportunity analysis is based on the company's stated targets and comparable market valuations.

Sources

1. [PR Newswire, October 2024] Persperity Health Secures $1 Million to rework Women's Health with Breakthrough Sweat-Sensing Technology | https://persperityhealth.com/revolutionizing-womens-health-persperity-healths-breakthrough-in-real-time-hormone-monitoring/
2. [Finsmes, 2024] Persperity Health Raises $1M in Pre-Seed Funding | https://www.finsmes.com/2024/11/persperity-health-raises-1m-in-pre-seed-funding.html
3. [Crunchbase] Persperity Health - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/persperity-health
4. [Perplexity Sonar Pro Brief] Persperity Health Brief | https://persperityhealth.com/revolutionizing-womens-health-persperity-healths-breakthrough-in-real-time-hormone-monitoring/
5. [Persperity Health] Revolutionizing Women’s Health: Persperity Health’s Breakthrough in Real-Time Hormone Monitoring | https://persperityhealth.com/revolutionizing-womens-health-persperity-healths-breakthrough-in-real-time-hormone-monitoring/
6. [PitchBook] Persperity Health 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/706882-33
7. [Grand View Research, 2024] Fertility Services Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/fertility-services-market
8. [Global Market Insights, 2024] Hormone Replacement Therapy Market Size | https://www.gminsights.com/industry-analysis/hormone-replacement-therapy-market
9. [CDC, 2023] National Vital Statistics Reports | https://www.cdc.gov/nchs/data/nvsr/nvsr72/nvsr72-01.pdf
10. [Yahoo Finance, March 2025] Progyny Inc. (PGNY) Stock Price & News | https://finance.yahoo.com/quote/PGNY/
11. [Crunchbase] Rockley Photonics Profile | https://www.crunchbase.com/organization/rockley-photonics